Clearside Biomedical, Inc.
CLSD
$3.70
-$0.39-9.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.71M | -30.81M | -34.35M | -31.88M | -33.46M |
| Total Depreciation and Amortization | 323.00K | 283.00K | 226.00K | 167.00K | 108.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.63M | 9.33M | 11.11M | 12.78M | 13.40M |
| Change in Net Operating Assets | -3.97M | -1.48M | -1.68M | -20.00K | 840.00K |
| Cash from Operations | -21.73M | -22.68M | -24.70M | -18.95M | -19.11M |
| Capital Expenditure | -506.00K | -929.00K | -977.00K | -653.00K | -1.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.35M | 339.00K | 339.00K | -9.41M | -11.01M |
| Cash from Investing | 10.85M | -590.00K | -638.00K | -10.07M | -12.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.52M | 2.54M | 16.44M | 15.10M | 15.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.50M | -1.00M | -- | -1.00M | -1.00M |
| Cash from Financing | 2.02M | 1.54M | 16.44M | 14.10M | 14.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.86M | -21.73M | -8.90M | -14.91M | -16.77M |